Can cognitive behaviour therapy be beneficial for heart failure patients?

Johan Lundgren1, Gerhard Andersson, Peter Johansson

  • 1Department of Social and Welfare Studies, Linköping University, Norrköping, Sweden.

Insights

Cognitive Behavioural Therapy (CBT) may help reduce depression and anxiety in heart failure (HF) patients. Further research is needed to optimize CBT program design and delivery for this population.

Area of Science:

  • Cardiology
  • Psychiatry
  • Behavioural Science

Background:

  • Heart failure (HF) patients frequently experience depression and anxiety.
  • Standard disease management programs show limited benefit for these psychological issues.
  • Cognitive Behavioural Therapy (CBT) offers a potential therapeutic approach.

Purpose of the Study:

  • To review the theoretical underpinnings of CBT.
  • To evaluate the existing evidence for CBT's efficacy in heart failure patients.
  • To identify gaps in current research regarding CBT for HF.

Main Methods:

  • Literature review of studies on CBT for heart failure.
  • Analysis of the theoretical framework of CBT, focusing on cognitive and behavioral change.
  • Assessment of study designs, including limitations such as small sample sizes and lack of randomization.

Main Results:

  • Current evidence, though limited, suggests CBT can reduce depression and anxiety in HF patients.
  • Relaxation techniques incorporating CBT elements may alleviate symptom burden.
  • The existing body of research is small and often lacks rigorous randomized controlled trial design.

Conclusions:

  • CBT shows promise as a treatment for psychological distress in heart failure.
  • More research is required to determine optimal CBT program structure, delivery settings, and personnel.
  • Implementation in clinical practice should be preceded by further investigation into practical aspects of CBT delivery for HF.

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
614
Cognitive Therapy01:25

Cognitive Therapy

Cognitive therapy, pioneered by Aaron T. Beck in the 1960s, is a structured approach to addressing psychological distress by focusing on the influence of thoughts on emotions and behaviors. All cognitive therapies involve the basic assumption that human beings have control over their feelings, and that how individuals feel about something depends on how they think about it. Unlike psychoanalytic methods that delve into unconscious processes or humanistic approaches emphasizing...
1.5K
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
1.2K
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
768
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.5K
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
594